Cargando…
Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
Artemisinin resistance has emerged and spread in the Greater Mekong Sub-region (GMS), followed by artemisinin-based combination therapy failure, due to both artemisinin and partner drug resistance. More worrying, artemisinin resistance has been recently reported and confirmed in Rwanda. Therefore, t...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513315/ https://www.ncbi.nlm.nih.gov/pubmed/34645475 http://dx.doi.org/10.1186/s12936-021-03942-5 |